Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$61.9 - $80.36 $4,333 - $5,625
70 New
70 $4,000
Q4 2023

Jan 31, 2024

SELL
$91.3 - $115.05 $1,643 - $2,070
-18 Reduced 32.73%
37 $4,000
Q3 2023

Oct 25, 2023

BUY
$97.55 - $135.91 $4,877 - $6,795
50 Added 1000.0%
55 $5,000
Q1 2023

Apr 26, 2023

BUY
$89.75 - $107.27 $448 - $536
5 New
5 $0
Q3 2022

Nov 10, 2022

SELL
$77.78 - $103.92 $22,867 - $30,552
-294 Reduced 70.84%
121 $10,000
Q2 2022

Aug 01, 2022

SELL
$88.23 - $154.18 $1,323 - $2,312
-15 Reduced 3.49%
415 $40,000
Q1 2022

Apr 21, 2022

SELL
$121.88 - $150.0 $61,427 - $75,600
-504 Reduced 53.96%
430 $64,000
Q4 2021

Jan 18, 2022

BUY
$129.86 - $157.03 $121,289 - $146,666
934 New
934 $132,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.